Dr. Matthijs has a PhD in pharmaceutical sciences and is a certified specialist in clinical molecular genetics. He is the head of the Laboratory for Molecular Diagnostics at the Center for Human Genetics in Leuven, Belgium, and a professor at the University of Leuven. His research interest is in CDG. The gene for CDG-Ia was first cloned in his laboratory, back in 1996, and his group has been involved in the elucidation of different other types of CDG. He is also the Coordinator of EUROGLYCANET, a European Network for the systematic study of CDG and related diseases (www.euroglycanet.org). The network offers expert testing for CDG, and is of course also interested in novel types of the disease. Leuven acts as a reference centre in the context of the network. The Laboratory for Molecular Diagnostics is offering genetic testing for the different types of CDG, including prenatal diagnosis.

Photo:
© EuroGenetest - “Harmonizing Genetic Testing Across Europe”